This is why people with active cancer or recent cancer history are advised to avoid use
Smaller Biotechs and Collaborators: Companies like Zealand Pharma, Glycadia, and others have GLP-1 analogs or co-agonists in early trials, often in partnership with larger pharma (e.g., Novo Nordisk collaboration with Zealand)
Given the high global prevalence of obesity and its strong association with type 2 diabetes and other chronic diseases, Retatrutide emerges as a highly promising research candidate
That distinction matters when youre perimenopausal, working a full-time job, managing a household, and the last thing you want is another weekly check-in with another app telling you to drink more water
on Ozempic but Was Bedridden with Nausea. January 2024
A report of the surgeon general